As an instance of the thesis that CXCL12 and its receptor CXCR4 are involved in the formation of blood vessels in RA, angiogenic properties of RA synovial fluid were significantly decreased after incubation with anti-CXCL12 antibodies [51]. The gene discussed is CXCR4; the disease is rheumatoid arthritis.